Mucormycosis and Anaesthesia
Not Applicable
- Conditions
- Health Condition 1: B465- Mucormycosis, unspecified
- Registration Number
- CTRI/2021/06/034357
- Lead Sponsor
- Dr Swati Datta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with RTPCR confirmed recent (with in last one & a half months) infection with SARS-COV-2 and current RTPCR negative status
2. Presence of more than 1 of following clinical features:
i) Frontal headache
ii) Blurring of vision
iii) Numbness of chick
iv) Facial swelling
v) Features suggestive of cranial nerve involvement
vi) Nasal or sinus congestion
vii) Black lesion on nasal bridge or upper inside of mouth (palatal region)
3. Undergoing surgical resection of rhino-orbito-cerebral mucormycoses
Exclusion Criteria
1. COVID-19 RTPCR positive mucormycosis
2. Patients with incomplete medical records
3. Post COVID mucormycosis patients who are critically ill, not undergoing surgical treatment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Sociodemographic profile of the post-COVID mucormycosis patients undergoing surgical intervention <br/ ><br>2. Etiology of increased frequency of mucormycosis in the post-COVID period <br/ ><br>3. Different anaesthetic challenges and ways to overcome them in post-COVID mucormycosis. <br/ ><br>4. Association, if any, of zinc supplementation with post-COVID mucormycosisTimepoint: One and half months
- Secondary Outcome Measures
Name Time Method 1. Duration of hospital stay <br/ ><br>2. Types of different surgeries performed <br/ ><br>3. Duration of anaesthesia <br/ ><br>4. Duration of mechanical ventilation in the post-operative period <br/ ><br>5. Ocular morbidity of patients undergoing surgery for post-COVID mucormycosis <br/ ><br>6. All cause mortalityTimepoint: one and half months